Programme: Bladder Cancer Europe Roundtable 2018

Wednesday 14th February, Brussels
Chair: Prof. Hendrik van Poppel, Adjunct Secretary General for Education, European Association of Urology

09:30 - 10:00 Registration and Morning Coffee
10:00 — 11:45

Session I: Analysing the Current Policy Framework of Bladder Cancer in the EU and Member States

  • Introduction & opening of roundtable
  • Viewpoint: Lieve Wierinck MEP, MEP’s Against Cancer Group Member, European Parliament
  • Viewpoint: Prof. Hendrik van Poppel, Adjunct Secretary General for Education, European Association of Urology
  • Current policy, guidelines and schemes in the EU and Member States
  • Reaching an harmonised registration programme within the EU: what are the next steps?
  • Education and training of medical professionals: how can we encourage mobility of European medical practitioners?
11:45 — 12:00 Coffee Break
12:00 — 13:00 Session II: Improving Early Prevention, Diagnosis and Patient Treatment
  • Early detection & screening: rationales, perspectives and risk groups
  • New modalities for imaging: narrow band imaging and photodynamic diagnosis
  • Improving the quality of care via minimal invasive surgical methods & therapies
  • Management of neobladder morbidity
  • New approaches to developing pharmaceutical treatments for elderly patients
  • How can we ensure the provision of a consistent treatment strategy across a multi-disciplinary team (MDT)?
13:00 — 14:00 Networking Lunch
14:00 — 15:15 Session III: Fostering Research, Innovation and Drugs Development
  • Immunotherapy combos and chemotherapy: are they the future of bladder cancer care?
  • Latest results on Urinary cytology and urinary markers non-invasive follow-up methods
  • Data protection and privacy: discussing the new EU General Data Protection Regulation (GDPR) and its potential effects on clinical trials
  • Clinical trials: how can we encourage them and seek high standard for patient safety?
  • Future technologies, advanced therapies and clinical developments: how can we improve market access and foster competitiveness?
15:15 — 15:45 Recommendations and Close of Roundtable
 
  • Recommendations for policy makers, governments and key stakeholders to support an EU-wide strategy : tour de table of each participant’s final recommendation for the Bladder Cancer Report
  • Chair’s closing remarks